Страна: Великобритания
Язык: английский
Источник: HMA (Heads of Medicines Agencies)
ceftiofur 50 mg/ml
Continental Farmaceutica
QJ01DD90
Suspension for injection
Ceftiofur
Cattle, Pigs
2010-07-30
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT IT: TRULEVA Fluid suspension, 50 mg/ml, suspension for injection for pigs and cattle DE, BE, FR and UK: TRULEVA Flow, 50 mg/ml, suspension for injection for pigs and cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Ceftiofur (as hydrochloride) 50.0 mg EXCIPIENT(S): For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Suspension for injection. Opaque suspension, white to off-white. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs and cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Infections associated with bacteria sensitive to ceftiofur: In pigs: For the treatment of bacterial respiratory disease associated with _Pasteurella multocida_, _Actinobacillus _ _pleuropneumoniae _and _Streptococcus suis_. In cattle: For the treatment of bacterial respiratory disease associated with _Mannheimia haemolytica (former _ _Pasteurella haemolytica), Pasteurella multocida and Histophilus somni (former Haemophilus somnus). _ For the treatment of acute interdigital necrobacillosis (panaritium, foot rot), associated with _Fusobacterium necrophorum _and _Bacteroides melaninogenicus _(_Porphyromonas asaccharolytica_). For treatment of the bacterial component of acute post-partum (puerperal) metritis within 10 days after calving associated with _Escherichia coli_, _Arcanobacterium pyogenes _and _Fusobacterium necrophorum_, sensitive to ceftiofur, where treatment with another antimicrobial has failed_. _ _ _ 4.3 CONTRAINDICATIONS Do not administer to Прочитать полный документ